Ajit Ramalingam's most recent trade in Bio-Rad Laboratories Inc. - Ordinary Shares - Class A was a trade of 241 Bio-Rad A Common Stock done . Disclosure was reported to the exchange on Sept. 1, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Bio-Rad Laboratories Inc. ...
|
Ajit Ramalingam | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 241 | 487 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
Bio-Rad Laboratories Inc. ...
|
Ajit Ramalingam | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 241 | 241 | - | - | Restricted Stock Units | |
Bio-Rad Laboratories Inc. ...
|
Ajit Ramalingam | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 173 | 196 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
Bio-Rad Laboratories Inc. ...
|
Ajit Ramalingam | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 173 | 521 | - | - | Restricted Stock Units | |
Bio-Rad Laboratories Inc. ...
|
Ajit Ramalingam | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 169 | 305 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
Bio-Rad Laboratories Inc. ...
|
Ajit Ramalingam | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 169 | 338 | - | - | Restricted Stock Units | |
Bio-Rad Laboratories Inc. ...
|
Ajit Ramalingam | SVP, Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.60 per share. | 01 Sep 2023 | 84 | 403 (0%) | 0% | 394.6 | 33,146 | Bio-Rad A Common Stock |
Bio-Rad Laboratories Inc. ...
|
Ajit Ramalingam | SVP, Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.60 per share. | 01 Sep 2023 | 60 | 136 (0%) | 0% | 394.6 | 23,676 | Bio-Rad A Common Stock |
Bio-Rad Laboratories Inc. ...
|
Ajit Ramalingam | SVP, Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.59 per share. | 01 Sep 2023 | 59 | 246 (0%) | 0% | 394.6 | 23,281 | Bio-Rad A Common Stock |
Bio-Rad Laboratories Inc. ...
|
Ajit Ramalingam | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 368.28 per share. | 06 Jun 2023 | 181 | 0 (0%) | 0% | 368.3 | 66,659 | Bio-Rad A Common Stock |
Bio-Rad Laboratories Inc. ...
|
Ajit Ramalingam | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 376.12 per share. | 06 Jun 2023 | 17 | 181 (0%) | 0% | 376.1 | 6,394 | Bio-Rad A Common Stock |
Bio-Rad Laboratories Inc. ...
|
Ajit Ramalingam | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2023 | 277 | 294 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
Bio-Rad Laboratories Inc. ...
|
Ajit Ramalingam | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2023 | 277 | 554 | - | - | Restricted Stock Units | |
Bio-Rad Laboratories Inc. ...
|
Ajit Ramalingam | SVP, Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 450.79 per share. | 29 Apr 2023 | 96 | 198 (0%) | 0% | 450.8 | 43,276 | Bio-Rad A Common Stock |
Bio-Rad Laboratories Inc. ...
|
Ajit Ramalingam | SVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2023 | 644 | 644 | - | - | Restricted Stock Units | |
Bio-Rad Laboratories Inc. ...
|
Ajit Ramalingam | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 421.70 per share. | 10 Nov 2022 | 267 | 112 (0%) | 0% | 421.7 | 112,594 | Bio-Rad A Common Stock |
Bio-Rad Laboratories Inc. ...
|
Ajit Ramalingam | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 422.28 per share. | 10 Nov 2022 | 112 | 0 (0%) | 0% | 422.3 | 47,295 | Bio-Rad A Common Stock |
Bio-Rad Laboratories Inc. ...
|
Ajit Ramalingam | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 241 | 482 | - | - | Restricted Stock Units | |
Bio-Rad Laboratories Inc. ...
|
Ajit Ramalingam | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 241 | 449 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
Bio-Rad Laboratories Inc. ...
|
Ajit Ramalingam | SVP, Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 478.32 per share. | 02 Sep 2022 | 84 | 365 (0%) | 0% | 478.3 | 40,179 | Bio-Rad A Common Stock |
Bio-Rad Laboratories Inc. ...
|
Ajit Ramalingam | SVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2022 | 694 | 694 | - | - | Restricted Stock Units | |
Bio-Rad Laboratories Inc. ...
|
Ajit Ramalingam | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2022 | 169 | 267 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
Bio-Rad Laboratories Inc. ...
|
Ajit Ramalingam | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2022 | 169 | 507 | - | - | Restricted Stock Units | |
Bio-Rad Laboratories Inc. ...
|
Ajit Ramalingam | SVP, Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 486.25 per share. | 01 Sep 2022 | 59 | 208 (0%) | 0% | 486.3 | 28,689 | Bio-Rad A Common Stock |
Bio-Rad Laboratories Inc. ...
|
Ajit Ramalingam | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 537.00 per share. | 05 Aug 2022 | 518 | 98 (0%) | 0% | 537 | 278,166 | Bio-Rad A Common Stock |
Bio-Rad Laboratories Inc. ...
|
Ajit Ramalingam | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2022 | 277 | 697 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
Bio-Rad Laboratories Inc. ...
|
Ajit Ramalingam | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2022 | 277 | 831 | - | - | Restricted Stock Units | |
Bio-Rad Laboratories Inc. ...
|
Ajit Ramalingam | SVP, Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 512.06 per share. | 29 Apr 2022 | 96 | 601 (0%) | 0% | 512.1 | 49,158 | Bio-Rad A Common Stock |
Bio-Rad Laboratories Inc. ...
|
Ajit Ramalingam | SVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2021 | 676 | 676 | - | - | Restricted Stock Units | |
Bio-Rad Laboratories Inc. ...
|
Ajit Ramalingam | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2021 | 240 | 473 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
Bio-Rad Laboratories Inc. ...
|
Ajit Ramalingam | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2021 | 240 | 723 | - | - | Restricted Stock Units | |
Bio-Rad Laboratories Inc. ...
|
Ajit Ramalingam | SVP, Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 825.77 per share. | 01 Sep 2021 | 83 | 390 (0%) | 0% | 825.8 | 68,539 | Bio-Rad A Common Stock |
Bio-Rad Laboratories Inc. ...
|
Ajit Ramalingam | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2021 | 276 | 317 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
Bio-Rad Laboratories Inc. ...
|
Ajit Ramalingam | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2021 | 276 | 1,108 | - | - | Restricted Stock Units | |
Bio-Rad Laboratories Inc. ...
|
Ajit Ramalingam | SVP, Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 640.73 per share. | 29 Apr 2021 | 96 | 221 (0%) | 0% | 640.7 | 61,510 | Bio-Rad A Common Stock |
Bio-Rad Laboratories Inc. ...
|
Ajit Ramalingam | SVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Sep 2020 | 963 | 963 | - | - | Restricted Stock Units | |
Bio-Rad Laboratories Inc. ...
|
Ajit Ramalingam | EVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2020 | 1,384 | 1,384 | - | - | Restricted Stock Units |